Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,084 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $524.10 | 10 | $0 (2024) |
| Novo Nordisk Inc | $239.20 | 14 | $0 (2024) |
| ABBVIE INC. | $197.79 | 8 | $0 (2024) |
| Lilly USA, LLC | $166.83 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $141.54 | 10 | $0 (2024) |
| PFIZER INC. | $135.80 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $100.80 | 6 | $0 (2024) |
| Welch Allyn | $99.98 | 2 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $84.00 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $58.41 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $454.14 | 25 | Lilly USA, LLC ($88.72) |
| 2023 | $223.15 | 12 | Novo Nordisk Inc ($96.88) |
| 2022 | $296.70 | 14 | ABBVIE INC. ($146.68) |
| 2020 | $350.25 | 20 | Welch Allyn ($99.98) |
| 2019 | $478.41 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($382.15) |
| 2018 | $227.06 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($71.54) |
| 2017 | $53.99 | 4 | GlaxoSmithKline, LLC. ($27.56) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: VACCINE | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Obesity | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: General - Therapies_CRM | ||||||
| 09/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Insulin Pump | ||||||
| 05/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Endocrinology | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: DIABETES | ||||||
| 03/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Oncology | ||||||
| 02/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 01/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,475 | 5,438 | $426,821 | $159,119 |
| 2022 | 44 | 3,452 | 5,189 | $395,555 | $150,804 |
| 2021 | 47 | 3,796 | 6,059 | $415,150 | $171,741 |
| 2020 | 40 | 3,898 | 6,519 | $405,213 | $154,799 |
All Medicare Procedures & Services
168 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 316 | 817 | $187,910 | $64,273 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 248 | 248 | $81,840 | $29,579 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 206 | $32,548 | $10,659 | 32.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 289 | 394 | $15,760 | $6,423 | 40.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 333 | 711 | $9,640 | $5,743 | 59.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 313 | 557 | $11,697 | $5,726 | 49.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 275 | 352 | $11,264 | $4,520 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 55 | 55 | $4,675 | $3,884 | 83.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,724 | $3,375 | 59.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $8,820 | $2,748 | 31.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 95 | 95 | $4,465 | $2,673 | 59.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 159 | 269 | $6,187 | $2,487 | 40.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 55 | 64 | $4,416 | $1,831 | 41.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 165 | 233 | $4,427 | $1,773 | 40.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 189 | 268 | $4,288 | $1,681 | 39.2% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 26 | 35 | $2,800 | $1,346 | 48.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 58 | 58 | $2,494 | $1,097 | 44.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 52 | 65 | $2,600 | $1,049 | 40.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 58 | 67 | $2,412 | $963.87 | 40.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 78 | 108 | $2,268 | $931.02 | 41.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 41 | 41 | $1,271 | $875.19 | 68.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 83 | $4,814 | $704.48 | 14.6% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 31 | 53 | $1,590 | $662.50 | 41.7% |
| 83735 | Magnesium level | Office | 2023 | 67 | 89 | $1,424 | $573.22 | 40.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 15 | $2,190 | $497.90 | 22.7% |
About Dr. Benjamin Bailey, MD
Dr. Benjamin Bailey, MD is a Family Medicine healthcare provider based in Greeneville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1740620103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Bailey, MD has received a total of $2,084 in payments from pharmaceutical and medical device companies, with $454.14 received in 2024. These payments were reported across 98 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,084).
As a Medicare-enrolled provider, Bailey has provided services to 14,621 Medicare beneficiaries, totaling 23,205 services with total Medicare billing of $636,463. Data is available for 4 years (2020–2023), covering 168 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Greeneville, TN
- Active Since 07/01/2013
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740620103
Products in Payments
- JARDIANCE (Drug) $475.02
- UBRELVY (Drug) $105.15
- ELIQUIS (Drug) $101.57
- RetinaVue 700 Imager (Device) $99.98
- VRAYLAR (Drug) $88.33
- Wegovy (Drug) $85.21
- NUEDEXTA (Drug) $84.00
- FARXIGA (Drug) $82.00
- Ozempic (Drug) $66.92
- SHINGRIX (Biological) $62.48
- ENTRESTO (Drug) $58.41
- TRULICITY (Drug) $51.26
- Dexcom G6 Transmitter (Medical Supply) $42.13
- Kerendia (Drug) $37.47
- MOUNJARO (Drug) $37.01
- Rybelsus (Drug) $31.51
- Victoza (Drug) $31.11
- CHANTIX (Drug) $29.51
- TRELEGY ELLIPTA (Drug) $28.48
- INVOKANA (Drug) $27.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greeneville
Carla Nickle, D.o, D.O
Family Medicine — Payments: $8,436
Dr. Claes Svendsen, Md, MD
Family Medicine — Payments: $8,345
Kenneth Nickle, Do, DO
Family Medicine — Payments: $7,766
Sonja Woods, Md, MD
Family Medicine — Payments: $7,552
Dr. Michael Odell, M.d, M.D
Family Medicine — Payments: $7,240
Sarah Knuettel, Do, DO
Family Medicine — Payments: $6,835